Literature DB >> 7141116

Effect of methylphenidate hydrochloride on stature of hyperactive children.

J E Kalachnik, R L Sprague, E K Sleator, M N Cohen, R K Ullmann.   

Abstract

Twenty-six hyperactive children receiving methylphenidate hydrochloride, eight hyperactive non-medicated children and 25 normal children participated in a study of the effect of such medication on stature of hyperactive children. All the children were below 13 years of age and all but two were male. Predicted adult stature before methylphenidate treatment and predicted adult stature after one year, two years and three years of treatment were calculated by means of the Roche-Weiner-Thissen Adult Stature Prediction Formula. Total milligrams per day dosage, milligrams per kilogram per day dosage and duration of treatment per year were analysed in the medicated hyperactive children and their growth was compared with the other two groups. No significant differences were found for any of the above variables. This study indicates that stature suppression does not occur in male children below 13 years of age when methylphenidate is used up to 0.8mg/kg/day for one or two years and up to 0.6mg/kg/day for three years.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7141116     DOI: 10.1111/j.1469-8749.1982.tb13669.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  4 in total

1.  Use of methylphenidate for attention deficit hyperactivity disorder. Mental Health Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1990-04-15       Impact factor: 8.262

Review 2.  Attention deficit hyperactivity disorder--a review.

Authors:  C Williams; B Wright; I Partridge
Journal:  Br J Gen Pract       Date:  1999-07       Impact factor: 5.386

Review 3.  Growth on stimulant medication; clarifying the confusion: a review.

Authors:  A Poulton
Journal:  Arch Dis Child       Date:  2005-08       Impact factor: 3.791

Review 4.  Risks and benefits of drugs used in the management of the hyperactive child.

Authors:  A M Fox; M J Rieder
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.